Lazard, Inc.

Description

Lazard, Inc., together with its subsidiaries, operates as a financial advisory and asset management firm in North and South America, Europe, the Middle East, Asia, and Australia. It operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical advisory, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services. This segment offers its services to corporate, partnership, institutional, government, sovereign, and individual clients to various industry areas, including consumers, financial institutions, healthcare and life sciences, industrials, power and energy/infrastructure, real estate, technology, telecommunication, and media and entertainment. The Asset Management segment offers a range of investment solutions; investment and wealth management services in equity and fixed income strategies; asset allocation strategies; and alternative investments and private equity funds to corporations, public funds, sovereign entities, endowments and foundations, labor funds, financial intermediaries, and private clients. Lazard, Inc. was incorporated in 1848 and is headquartered in New York, New York.

About

CEO
Mr. Peter R. Orszag
Employees
3,249
Instrument type
Common Stock
Sector
Financial Services
Industry
Capital Markets
MIC code
XNYS
Address
30 Rockefeller Plaza, New York, NY 10112, United States
Phone
212-632-6000
Website
Chart Image
× Enlarged Chart
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Oct 29, 2025
Jul 23, 2025
Apr 23, 2025
Jan 30, 2025 0.55 0.78 0.23 41.82%
Oct 31, 2024 0.40 0.38 -0.02 -5.00%

Earnings estimate

Current Quarter
(Mar 2025)
Next Quarter
(Jun 2025)
Current Year
(Dec 2025)
Next Year
(Dec 2026)
Number of analysts 7 8 9 8
Average estimate 0.72 0.76 3.76 4.76
Low estimate 0.54 0.66 3.49 4.44
High estimate 0.89 0.90 4.12 5.44
Last year EPS 0.66 0.52 2.34 3.76
[stock_revenue_estimate]

Growth estimates

Current qtr (Mar 2025)
7.380%
Next qtr. (Jun 2025)
47.290%
Current year (Dec 2025)
58.590%
Next year (Dec 2026)
28.270%
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target
Jan 31, 2025
Morgan Stanley
Ryan Kenny
Maintains Equal-Weight ▲ Raises $60 → $63
Jan 31, 2025
Keefe, Bruyette & Woods
Aidan Hall
Maintains Market Perform ▲ Raises $52 → $57
Jan 31, 2025
Wells Fargo
Michael Brown
Maintains Equal-Weight ▲ Raises $51 → $55
Jan 15, 2025
Goldman Sachs
Richard Ramsden
Maintains Sell ▼ Lowers $51 → $44
Jan 14, 2025
Wells Fargo
Michael Brown
Maintains Equal-Weight ▼ Lowers $59 → $51
Jan 13, 2025
Keefe, Bruyette & Woods
Aidan Hall
Maintains Market Perform ▼ Lowers $57 → $52
Jan 3, 2025
Wolfe Research
Brendan O'Brien
Downgrade Peer Perform
Dec 20, 2024
Keefe, Bruyette & Woods
Aidan Hall
Downgrade Market Perform ▼ Lowers $65 → $57
Dec 9, 2024
Morgan Stanley
Ryan Kenny
Downgrade Equal-Weight ▲ Raises $60 → $63
Nov 1, 2024
JMP Securities
Devin Ryan
Maintains Market Outperform ▲ Raises $55 → $59
Nov 1, 2024
Keefe, Bruyette & Woods
Aidan Hall
Maintains Outperform ▲ Raises $59 → $65
Oct 9, 2024
JMP Securities
Devin Ryan
Maintains Market Outperform ▲ Raises $52 → $55
Oct 8, 2024
UBS
Brennan Hawken
Maintains Neutral ▲ Raises $49 → $52
Sep 23, 2024
Morgan Stanley
Ryan Kenny
Maintains Overweight ▲ Raises $56 → $60
Sep 12, 2024
Wells Fargo
Michael Brown
Initiates Equal-Weight Announces $51
Jul 26, 2024
Goldman Sachs
Richard Ramsden
Maintains Sell ▲ Raises $38 → $42
Jul 26, 2024
Keefe, Bruyette & Woods
Aidan Hall
Reiterates Outperform ▲ Raises $49 → $56
Jul 23, 2024
Morgan Stanley
Ryan Kenny
Maintains Overweight ▲ Raises $53 → $56
Jun 21, 2024
Morgan Stanley
Ryan Kenny
Maintains Overweight ▼ Lowers $58 → $54
Apr 26, 2024
Keefe, Bruyette & Woods
Aidan Hall
Reiterates Outperform ▼ Lowers $51 → $49
Apr 11, 2024
Morgan Stanley
Ryan Kenny
Maintains Overweight Maintains $58
Mar 26, 2024
UBS
Brennan Hawken
Maintains Neutral ▲ Raises $43 → $44
Feb 5, 2024
UBS
Brennan Hawken
Maintains Neutral ▲ Raises $40 → $43
Jan 29, 2024
Keefe, Bruyette & Woods
Michael Brown
Reinstates Outperform Announces $51
Jan 9, 2024
UBS
Brennan Hawken
Maintains Neutral ▲ Raises $31 → $40
Jan 3, 2024
Wolfe Research
Steven Chubak
Upgrade Outperform Announces $42
Dec 19, 2023
Goldman Sachs
Richard Ramsden
Maintains Sell ▲ Raises $28 → $31
Oct 27, 2023
Morgan Stanley
Ryan Kenny
Maintains Overweight ▲ Raises $41 → $45
Oct 12, 2023
Morgan Stanley
Ryan Kenny
Maintains Overweight ▼ Lowers $42 → $41
Oct 10, 2023
JMP Securities
Devin Ryan
Maintains Market Outperform ▼ Lowers $53 → $50

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 2.55B 2.83B 3.27B 2.64B 2.65B
Cost of revenue 1.95B 1.66B 1.90B 1.55B 1.56B
Gross profit 605.13M 1.17B 1.37B 1.09B 1.09B
Operating expense
Research & development
Selling general and admin 430.66M 384.87M 379.00M 339.48M 424.08M
Other operating expenses 218.44M 215.35M 194.28M 172.04M 187.19M
Operating income -44.31M 568.91M 799.07M 577.11M 476.51M
Non operating interest income
Income 42.02M 29.46M 5.55M 5.67M 15.79M
Expense 77.67M 81.52M 80.77M 80.63M 80.19M
Other income expense -60,000 -1.80M -19.41M
Pretax income -79.96M 516.85M 723.85M 502.14M 392.70M
Tax provision -22.65M 124.37M 181.30M 99.45M 94.98M
Net income -57.31M 392.48M 542.55M 402.69M 297.72M
Basic EPS -0.90 3.68 4.90 3.69 2.57
Diluted EPS -0.90 3.51 4.63 3.54 2.44
Basic average shares 88.99M 95.66M 106.04M 106.86M 110.19M
Diluted average shares 88.99M 95.66M 106.04M 106.86M 110.19M
EBITDA 40.90M 640.77M 842.99M 619.66M 547.28M
Net income from continuing op. -57.31M 392.48M 542.55M 402.69M 297.72M
Minority interests -18.17M -34.97M -14.48M -231,000 -11.22M
Preferred stock dividends 4.44M 5.73M 8.65M 7.67M 3.39M

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4.64B 5.85B 7.15B 5.97B 5.64B
Current assets
Cash 1.23B
Cash equivalents 2.41B
Cash and cash equivalents 971.32M 1.23B 1.47B 1.39B 1.23B
Other short term investments 219.58M 779.25M 1.35B 1.13B 1.18B
Accounts receivable 762.32M 652.76M 805.81M 743.14M 663.14M
Other receivables
Inventory
Prepaid assets 233.42M 217.84M 238.16M 183.86M 117.70M
Restricted cash 34.09M 625.38M 617.45M 44.49M 43.28M
Assets held for sale
Hedging assets
Other current assets
Non current assets
Properties 407.21M 431.61M 466.05M 513.92M 551.50M
Land and improvements
Machinery furniture equipment 230.71M 236.19M 218.53M 240.83M 215.25M
Construction in progress 11.79M 65.56M 46.05M 42.82M 32.48M
Leases 233.73M 208.32M 209.47M 220.98M 197.36M
Accumulated depreciation -414.55M -395.11M -367.51M -402.47M -367.55M
Goodwill 789.83M 754.57M 758.99M 767.93M 745.37M
Investment properties
Financial assets 61.68M 56.95M 49.76M
Intangible assets 30,000 90,000 150,000 210,000 1.82M
Investments and advances 640.28M 642.03M 957.58M 658.53M 532.00M
Other non current assets 608.73M 510.90M 520.95M 612.78M 667.21M
Total liabilities 4.07B 4.59B 5.49B 4.97B 4.96B
Current liabilities
Accounts payable
Accrued expenses 195.57M 196.62M 197.44M 180.72M 179.28M
Short term debt
Deferred revenue 140.42M 137.33M 130.66M 90.72M 97.96M
Tax payable 253.14M 308.50M 383.28M 361.16M 385.71M
Pensions
Other current liabilities
Non current liabilities
Long term debt 2.18B 2.20B 2.24B 2.29B 2.32B
Provision for risks and charges
Deferred liabilities 3.86M 3.92M 1.83M 1.04M 3.51M
Derivative product liabilities
Other non current liabilities 49.07M 37.80M 54.51M 52.80M 67.30M
Shareholders equity
Common stock 1.13M 1.13M 1.13M 1.13M 1.13M
Retained earnings 1.40B 1.68B 1.56B 1.30B 1.19B
Other shareholders equity -289.95M -295.85M -223.85M -238.37M -293.65M
Total shareholders equity 569.86M 1.26B 1.65B 999.43M 681.57M
Additional paid in capital 247.20M 167.89M 144.73M 135.44M 41.02M
Treasury stock 937.26M 993.41M 507.43M 281.81M 332.08M
Minority interest 146.10M 702.41M 677.74M 87.66M 71.58M

Cash flow statement

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities
Net Income-57.31M392.48M542.55M402.69M297.72M532.45M259.85M393.69M992.93M434.06M165.11M92.79M190.56M194.42M-188.25M-239,000155.04M92.99M143.49M246.97M
Depreciation43.19M42.40M38.38M36.89M54.98M18.21M41.01M68.51M38.61M40.85M44.86M39.21M36.50M30.58M27.53M25.42M38.26M40.60M18.24M16.94M
Deferred Taxes-124.96M41.50M92.84M46.71M24.37M38.89M298.62M63.66M-553.09M33.94M15.70M-4.46M7.21M8.12M-23.43M-31.65M-16.39M-4.29M-7.56M452,000
Stock-Based Compensation
Other Non-Cash Items493.08M466.87M468.14M411.64M425.87M371.43M359.38M329.16M320.47M295.83M310.04M360.75M300.29M316.23M64.51M182.64M151.72M122.32M87.55M
Accounts Receivable-100.50M140.75M-81.61M-72.15M35.69M-131.64M95.98M-156.13M33.15M-76.20M-30.13M31.16M61.15M-52.69M-26.36M348.41M229.51M
Accounts Payable
Other Assets & Liabilities-192.68M122.58M-217.86M-249.85M-167.19M-136.83M372.03M4.61M-1.44M-171.69M-64.88M-108.55M-13.20M-309.67M67.32M509.89M-311.17M
Operating Cash Flow60.81M1.21B842.43M575.93M671.45M692.52M1.43B703.50M830.63M556.79M440.71M410.90M582.51M186.99M-143.19M916.34M277.88M281.01M276.49M351.92M
Investing Activities
Capital Expenditures-27.81M-48.94M-39.06M-62.94M-42.25M-46.21M-26.92M-37.65M-25.95M-20.10M-54.55M-84.93M-45.28M-12.95M-11.33M-17.77M-14.53M-8.19M3.88M-10.41M
Net Intangibles
Net Acquisitions-10.52M-39.14M-74.86M-135.06M
Purchase of Investments-139.56M-147.34M-73.24M
Sale of Investments373.24M93.47M88.03M
Investing Cash Flow-38.32M-56.44M-39.06M-62.94M-42.25M-46.21M-26.92M-37.65M-25.95M-20.10M-54.55M-84.93M-45.28M360.29M-96.56M-151.93M-222.82M-8.19M15.57M-1.69M
Financing Activities
Long-Term Debt Issuance492.03M490.97M296.76M396.27M493.40M593.49M3.56M578.42M15.05M
Long-Term Debt Payments-255.75M-255.54M-103.06M-510.92M-2.17M-581.12M-2.52M-134.15M-12.78M-3.62M-482.02M-147.42M-35.70M-96.17M-16.42M
Other Financing Charges-1.24B-446.53M290.94M-182.89M169.23M61.34M397.58M18.98M-48.58M-8.86M-12.72M-26.25M-48.26M275,000-64.73M-92.38M-21.86M-69.45M-2.47B-468.51M
Financing Cash Flow-1.52B-1.32B263.85M-474.72M-344.09M-615.74M-250.61M-423.68M-626.69M-349.93M-354.54M-518.34M-458.61M-220.31M-165.56M-444.96M243.27M-115.07M-1.99B-469.89M
Other Cash Details
End Cash Position1.22B2.64B3.43B2.57B2.46B2.29B2.45B1.61B1.13B1.07B841.48M850.19M1.00B1.21B917.33M909.71M1.06B969.48M492.31M305.75M
Income Tax Paid44.23M144.31M74.10M43.75M89.45M101.67M48.74M72.42M60.72M49.24M22.62M23.27M35.04M69.45M31.48M111.82M81.68M
Interest Paid73.68M77.44M77.99M78.26M70.40M50.81M49.60M46.26M45.36M60.41M78.67M78.44M92.70M102.11M99.49M142.89M141.35M
Free Cash Flow136.37M784.47M826.38M511.65M635.20M649.45M1.00B593.85M860.67M713.83M465.73M392.61M351.36M155.42M232.86M487.39M55.29M229.85M894.56M523.65M

Top Institutional Holders

Holder Date Reported Shares Value % Held
Smallcap World Fund Sep 30, 2024 3,746,261 195.55M 3.32%
Vanguard Total Stock Market Index Fund Sep 30, 2024 3,386,310 176.77M 3.00%
Vanguard Small-Cap Index Fund Sep 30, 2024 2,681,438 139.97M 2.38%
Fidelity Low-Priced Stock Fund Oct 31, 2024 2,570,604 134.19M 2.28%
iShares Select Dividend ETF Nov 30, 2024 2,358,154 123.10M 2.09%
Ariel Fund Sep 30, 2024 2,013,817 105.12M 1.79%
Vanguard Small Cap Value Index Fund Sep 30, 2024 1,815,331 94.76M 1.61%
Vanguard Extended Market Index Fund Sep 30, 2024 1,696,029 88.53M 1.50%
Fidelity Small Cap Value Fund Oct 31, 2024 1,319,300 68.87M 1.17%
Invesco Small Cap Value Fd Oct 31, 2024 1,068,800 55.79M 0.95%
Lazard Stock Gains as Earnings & Revenues Beat Estimates in Q4 Article
Lazard Stock Gains as Earnings & Revenues Beat Estimates in Q4
LAZ's fourth-quarter 2024 results benefit from higher revenues, and increased loans and deposit balances.
Zacks Investment Research Positive
Jan 31, 2025
Lazard: Healthy Backlog Into Next Year, But Peers Are Competitively Valued Article
Lazard: Healthy Backlog Into Next Year, But Peers Are Competitively Valued
Lazard, Inc. reported $10 billion in won but not yet funded mandates, meaning they have healthy commissions to be earned in the coming year. LAZ is aggressively hiring MDs, aiming to put them to work in a more deal abundant 2025. Asset management saw outflows but concentrated in low-fee accounts, muting revenue impacts expected into the next year.
Seeking Alpha Positive
Jan 31, 2025
Lazard CEO: Ahead of schedule on the pathway to Lazard 2030 Video
Lazard CEO: Ahead of schedule on the pathway to Lazard 2030
Peter Orszag, Lazard CEO, joins 'Squawk on the Street' to discuss the company's latest earnings results, the pipeline for capital markets activity, and much more.
CNBC Television Positive
Jan 30, 2025
Scroll to Top

Markets

Crypto

how to invest

Who we are